Clever Leaves Holdings Inc. CLVR CLVRW has entered into a five-year agreement with SOMAÍ Pharmaceuticals, to supply its operations in Portugal with EU-GMP certified CBD extracts from Colombia.
With the first shipments under the agreement already completed, Clever Leaves will continue to supply EU-GMP pharmaceutical-grade APIs and CBD extracts, produced in the company’s facility in Colombia, to SOMAÍ for further processing into finished products for patients across Europe. These are the first commercial shipments Clever Leaves has sent to Portugal, adding to the more than 15 countries that Clever Leaves has exported to from its European Union Good Manufacturing Practices certified facility in Colombia.
“By combining our expertise in producing and developing high-quality pharmaceutical-grade products with SOMAÍ's innovative approach to drug delivery systems, we aim to streamline patient access to pharmaceutical-grade cannabis products throughout Europe. This collaboration signifies Clever Leaves’ commitment to shaping the future of the global medical cannabis industry and grows our position in Europe's rapidly expanding medical cannabis market,” stated Andres Fajardo, CEO and co-founder of Clever Leaves.
Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals, stated “SOMAÍ Pharmaceuticals embarked on an extensive quest to seek a formidable partner to launch one of the most comprehensive cannabis product lines for the flourishing European markets. We are proud to be working with the highly professional Clever Leaves team and are most impressed with the high-quality EU-GMP CBD extract. We look forward to further collaborations with Clever Leaves to propel our product lines with even more advanced formulations and delivery methods.”
Photo: Benzinga edit with photos by geralt, lindsayfox on Pixabay
Related News
Clever Leaves' Q1 Net Loss Drops Significantly After Operating Expenses Slashed By 48%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!